Sign Up | Log In | What is SocialPicks?

7 pts

Opinion on Pfizer Inc (PFE) Sector: Healthcare > Industry: Major Drugs
Pfizer Inc

Jun 25, 2008 07:56 AM GMT

Marian Filo

Return	Risk
-24.55%	HIGH

Principal

Profile & Performance

Subscribe to author

Pfizer (PFE)
Click Here for the Strategy Report on this major drug manufacturer company
Stocks Covered: Pfizer (PFE)
Target Returns: 7.56% or 15.33% Annualized *
Downside Protection: Up to 6.12%
Duration: 180 Days
Investor Level: Beginner to Advanced
Risk Level: Moderate Relative Risk

Analysts' Recommendation:	Buy
30 Days Ago:	Buy

Analysts' Target:	$21

Analysts' Targets
UBS Securities	$21
Add
Tuesday, May 27, 2008

Update 06/08:

Pfizer (PFE) announced FDA...

Pfizer (PFE) announced FDA approval for Palladia (toceranib phosphate), used to treat mast-cell tumors in dogs on 6/4/09. Palladia marks the first cancer therapy for dogs to be approved for use in the United States and could be available to veterinarians in early 2010

PFE: This call was made on 06/25/08 @ $17.74

Rating:	$17.74 (06/25/08)
Gain/Loss:	+4.79% in 518 days
Allocation:	0.8% of portfolio

Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment

ROCK-STAR INVESTORS

Rank	Name	Sharpe Ratio	Avg Return	Followers
1	noshoes	21.10	+34.25%	381
2	Gerald Greene	18.14	+72.34%	210
3	stockmarketfunding.com	17.66	+25.65%	55
4	akiralegrand	13.47	+14.32%	61
5	anup2104	12.13	+76.91%	39

... more »

POPULAR STOCKS

Symbol	Company Name	Sentiment
POT	Potash Corp. of Saskatchewan Inc.
AMZN	Amazoncom Inc
GE	General Electric Company
JPM	JPMorgan Chase & Co
AIG	American International Group Inc.
NVDA	NVIDIA Corp

... more »

TODAY'S HEADLINES

LDK Solar's Growth Potential Offset by Gross Margin Pressure
by Paul Cheung (Zacks.com) about LDK

Cisco Systems Still a Wait and See
by Thomas Catino (Ant & Sons) about CSCO

The Merrill Lynch Diet: Starving Shareholders
by Zack Miller (BloggingStocks) about MER

Until Housing Improves, Don't Expect Stocks to Rebound
by J.D. Steinhilber (Agile Investing) about SPY

Google Blows Q2: Multiple Compression to Continue
by Henry Blodget about GOOG

... more »

TODAY'S TOP PICKS

CLDA		BioMed Research Reports: Clinical Data (NASDAQ: CLDA), Lpath (OTC: ... by Mike Havrilla
PARD		Biotech Stocks - Beware of The Covered Call Trap by Ivan Mutaftchiev
PBIO		Under the Radar Healthcare Stocks: Protox, Pressure BioSciences, Un... by Mike Havrilla
ISIS		ISIS - Last Tuesday's Drop Presents a Nice Buy Opportunity by Ivan Mutaftchiev
ABIO		BioMed News Bytes: Transcept, ProUroCare, SciClone, ABIO by Mike Havrilla

... more »

Pfizer Inc (PFE)

SocialPicks Sentiment:

This Quarter's Sentiment:

All:

69.5%

Top:

40.0%

Get Daily Email Alerts

Subscribe to Marian Filo

Receive Free Ideas Daily for This Sector

Latest Picks by Marian Filo

Symbol	SP Sentiment	Return	Since
IBB		-0.06%	11/16/09
ARE		-5.74%	11/16/09
ESE		+2.55%	11/16/09
SSY	N/A	-9.31%	11/16/09
NLST	N/A	+44.97%	11/16/09

View All >

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.

Opinion on Pfizer Inc (PFE) Sector: Healthcare > Industry: Major Drugs Pfizer Inc

Opinion on Pfizer Inc (PFE) Sector: Healthcare > Industry: Major Drugs
Pfizer Inc